E-DRUG: Heat-stable carbetocin and tranexamic acid for prevention and treatment of postpartum haemorrhage in LRS
---------------------------------------------------------------------------
Dear E-druggers,
I found only now this commentary published in BMJ Global Health some time ago, and thought it may be of interest for many of us:
https://gh.bmj.com/content/7/4/e008913
I copy-paste the Summary Box below:
* Heat-stable carbetocin, a uterotonic used for postpartum haemorrhage (PPH) prevention and tranexamic acid, an antifibrinolytic indicated for PPH treatment, are recently recommended medications.
* The growing number of medications in the PPH prevention and treatment toolkit can challenge policymakers, programme managers and clinicians operating in resource-constrained settings in deciding where and how to invest limited resources to achieve the best possible maternal health outcomes.
* This paper argues that there is no one-size-fits-all approach to implementing international PPH prevention and treatment guidance.
* A programmatic strategy tailored to the different levels of maternity care and the availability of skilled providers and cold chain systems is proposed.
Best wishes,
Raffaella Ravinetto
Institute of Tropical Medicine
Antwerp, Belgium
Raffaella Ravinetto <rravinetto@itg.be>